Joshua M. Hare, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Vestion, Inc.(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Heart Genomics(SIGNIFICANT), Vestion, Inc.(SIGNIFICANT), Biscayne Pharmaceuticals(SIGNIFICANT), Longeveron(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: NHLBI(SIGNIFICANT)

View Full Disclosure